InvestorsHub Logo
Post# of 252956
Next 10
Followers 45
Posts 3204
Boards Moderated 0
Alias Born 12/29/2003

Re: DewDiligence post# 74100

Monday, 03/09/2009 9:02:59 AM

Monday, March 09, 2009 9:02:59 AM

Post# of 252956
Every data point including side effects and dropout rates weren't in their favor. Further, assuming telapravir gets approved all its data is with Pegasys. I'm not completely sure approval will be a cinch. Either way look for Albuferon to be a commercial flop.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.